LifePoint Health Inc (NASDAQ:LPNT) – Stock analysts at Oppenheimer issued their Q1 2019 earnings per share estimates for LifePoint Health in a report issued on Tuesday. Oppenheimer analyst M. Wiederhorn expects that the company will earn $1.06 per share for the quarter. Oppenheimer also issued estimates for LifePoint Health’s Q2 2019 earnings at $1.02 EPS, Q3 2019 earnings at $1.03 EPS, Q4 2019 earnings at $1.20 EPS and FY2019 earnings at $4.31 EPS.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings data on Friday, October 27th. The company reported $0.80 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.94 EPS.
LPNT has been the topic of a number of other research reports. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the company a “buy” rating in a report on Monday, October 30th. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. Zacks Investment Research downgraded LifePoint Health from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Goldman Sachs Group initiated coverage on LifePoint Health in a report on Wednesday, January 3rd. They set a “sell” rating and a $45.00 price target on the stock. Finally, BMO Capital Markets initiated coverage on LifePoint Health in a report on Monday, October 16th. They set a “market perform” rating and a $59.00 price target on the stock. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $59.14.
LifePoint Health (NASDAQ:LPNT) traded up $0.45 on Wednesday, hitting $48.70. The stock had a trading volume of 310,679 shares, compared to its average volume of 619,675. The stock has a market capitalization of $1,900.00, a P/E ratio of 11.54, a P/E/G ratio of 1.14 and a beta of 0.67. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health has a 1 year low of $42.50 and a 1 year high of $70.95.
LifePoint Health announced that its Board of Directors has approved a share repurchase program on Friday, October 27th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.
In other LifePoint Health news, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 8.76% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the business. American Century Companies Inc. boosted its position in LifePoint Health by 7.7% during the 3rd quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock valued at $210,205,000 after acquiring an additional 260,944 shares in the last quarter. Vanguard Group Inc. boosted its position in LifePoint Health by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock valued at $222,299,000 after acquiring an additional 43,504 shares in the last quarter. State Street Corp boosted its position in LifePoint Health by 2.1% during the 2nd quarter. State Street Corp now owns 1,132,914 shares of the company’s stock valued at $76,075,000 after acquiring an additional 23,552 shares in the last quarter. Victory Capital Management Inc. boosted its position in LifePoint Health by 19.3% during the 3rd quarter. Victory Capital Management Inc. now owns 973,978 shares of the company’s stock valued at $56,393,000 after acquiring an additional 157,831 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in LifePoint Health by 28.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock valued at $46,044,000 after acquiring an additional 177,329 shares in the last quarter.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.